Classification
- Anatomical main groupVVarious
- Therapeutic subgroupV03
- Pharmacological subgroupV03A
- Chemical subgroupV03AF
- Chemical substanceV03AF02Dexrazoxane
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 5 registrations
- Dexrazoxane for Injection250 MG / VIAL · Powder For Solution · Juno Pharma Canada INC.
- Dexrazoxane for Injection250 MG / VIAL · Powder For Solution · Hikma Canada Limited
- Zinecard250 MG / VIAL · Powder For Solution · Pfizer Canada Ulc
- Zinecard500 MG / VIAL · Powder For Solution · Pfizer Canada Ulc
United States
FDA · 3 registrations
At a glance
- ATC code
- V03AF02
- ATC group
- Various
- Registers
- 8
- Registrations
- 16
- With their own page
- 15
- Companies
- 8
All medicines with Dexrazoxane
Human medicines from every register that match Dexrazoxane by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
16 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Dexrazoxane Hydrochloride | United States | 250MG BASE/VIAL, 500MG BASE/VIAL | injectable | Marketed | MSN |
| Dexrazoxane for Injection | Canada | 250 MG / VIAL | Powder For Solution | Marketed | Juno Pharma Canada INC. |
| Dexrazoxane for Injection | Canada | 250 MG / VIAL | Powder For Solution | Marketed | Hikma Canada Limited |
| Totect | United States | 500MG BASE/VIAL | injectable | Not marketed | Clinigen |
| Zinecard | United States | 250MG BASE/VIAL, 500MG BASE/VIAL | injectable | Not marketed | Pfizer |
| CARDIOXANE 500 mg POLVO PARA SOLUCION PARA PERFUSION | Spain | 500 mg | polvo para solución para perfusión | Marketed | Cnx Therapeutics Ireland Limited |
| Cardioxane | Brazil | Authorised | Adium S.A. | ||
| Savene | European Union | Authorised | CNX Therapeutics Ireland Limited | ||
| SAVENE 20 mg/ml POLVO PARA CONCENTRADO Y DISOLVENTE PARA SOLUCION PARA PERFUSION | Spain | 20 mg | polvo y disolvente para concentrado para solución para perfusión | Marketed | Cnx Therapeutics Ireland Limited |
| Cardioxane 500 mg poeder voor oplossing voor infusie | Netherlands | Poeder voor oplossing voor infusie | Authorised | CNX Therapeutics Ireland Limited | |
| Savene 500 mg, poeder en oplosmiddel voor oplossing voor infusie | Netherlands | Oplosmiddel voor parenteraal gebruik, Poeder voor oplossing voor injectie | Authorised | CNX Therapeutics Ireland Limited | |
| e.g. Cardioxane | New Zealand | Inj 500 mg | Funded | ||
| Zinecard | Canada | 250 MG / VIAL | Powder For Solution | Marketed | Pfizer Canada Ulc |
| Savene | Croatia | Authorised | |||
| Zinecard | Canada | 500 MG / VIAL | Powder For Solution | Not marketed | Pfizer Canada Ulc |
| Dexrazoxane for Injection | Canada | 500 MG / VIAL | Powder For Solution | Cancelled | Juno Pharma Canada INC. |